| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.13B | 1.14B | 1.19B | 1.59B | 1.21B | 966.67M |
| Gross Profit | 349.62M | 418.94M | 387.46M | 377.37M | 441.71M | 378.88M |
| EBITDA | 388.88M | 507.59M | 472.14M | 470.33M | 519.56M | 456.88M |
| Net Income | 49.16M | 62.39M | 54.28M | 64.17M | 82.55M | 66.17M |
Balance Sheet | ||||||
| Total Assets | 1.27B | 1.29B | 1.32B | 1.37B | 1.48B | 1.36B |
| Cash, Cash Equivalents and Short-Term Investments | 37.94M | 58.32M | 58.62M | 64.78M | 17.06M | 17.15M |
| Total Debt | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M |
| Total Liabilities | 458.30M | 458.64M | 460.59M | 468.27M | 508.00M | 441.35M |
| Stockholders Equity | 503.18M | 518.70M | 522.51M | 534.50M | 536.55M | 519.97M |
Cash Flow | ||||||
| Free Cash Flow | 209.10M | 436.03M | 405.18M | 409.62M | 327.27M | 336.43M |
| Operating Cash Flow | 292.56M | 485.00M | 452.00M | 463.74M | 408.44M | 373.40M |
| Investing Cash Flow | 11.54M | -88.97M | -75.94M | -12.00M | -64.30M | 2.03M |
| Financing Cash Flow | -326.37M | -396.33M | -382.23M | -404.01M | -344.24M | -378.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | $677.07M | 13.77 | 9.61% | 9.72% | -0.82% | -20.35% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | $439.23M | 8.50 | 6.62% | 3.91% | -5.05% | 35.01% | |
58 Neutral | $626.64M | -828.30 | -0.13% | ― | 12.49% | 95.48% | |
57 Neutral | $700.80M | -2.18 | -18.65% | 7.85% | -7.81% | -334.15% | |
49 Neutral | $383.94M | -0.92 | -78.11% | ― | -9.75% | -386.63% | |
47 Neutral | $1.08B | -1.20 | ― | ― | -10.68% | 36.31% |
On October 28, 2025, Westlake Chemical OpCo LP and Westlake Corporation renewed their Ethylene Sales Agreement and Feedstock Supply Agreement through December 31, 2027, ensuring stable and predictable cash flows for the Partnership. The renewal aligns with the Services and Secondment Agreement and includes amendments to the Omnibus Agreement, which addresses procedural requirements for Westlake’s indemnification obligations. The Partnership reported a decrease in third quarter 2025 net income and cash flows compared to 2024, primarily due to higher maintenance capital expenditures, but maintained a stable cash flow structure through its Ethylene Sales Agreement with Westlake.